scorecardresearch
Business Today
Subscribe
Visual Stories Immersives UPSTART India BTShorts Weather BT Bazaar
BT Golf BT Golf BT-TR GCC Listing
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • zero mile samvad iim nagpur
News
Markets
Stocks
Aarti Drugs Ltd

Feedback
Aarti Drugs Ltd

Aarti Drugs Ltd (AARTIDRUGS) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 104,025
Apr 01, 2024 12:25 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹452.30
₹18.00 (3.37%)
₹436.5 Low
Today’s Performance
₹452.95 High
₹332.05 Low
52 Week’s Performance
₹645.75 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day 3.37%
  • 1 Week -2.95%
  • 1 Month -13.26%
  • 3 Months -11.98%
  • 6 Months -19.74%
  • 1 Year 24.57%
  • 3 Years -15.04%
  • 5 Years 21.80%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 0.62
  • 52-Week Low (₹) 332.05
  • 52-Week High (₹) 645.75
  • Price-to-Book (X)* 3.30
  • Dividend Yield (%) 0.23
  • Price-to-Earnings (P/E) (X)* 22.14
  • Earnings Per Share (₹) 19.60
  • Sector Price Earning (X)* 36.52
  • Market Cap (₹ Cr.)* 3,992.74
  • * Vaues as of last close price

COMPETITORS

BT TV

India's Furious Pushback Against US And Germany Over Kejriwal Remarks 4:08 India's Furious Pushback Against US And Germany Over Kejriwal Remarks
Driving Forces Behind India’s Real Estate Surge 1:33 Driving Forces Behind India’s Real Estate Surge
India Sotheby's Amit Goyal: Housing Prices To Rise 8-10% Annually 2:21 India Sotheby's Amit Goyal: Housing Prices To Rise 8-10% Annually
Dy CM D K Shivakumar's Brother D K Suresh Battles It Out With C N Manjunath At Bengaluru Rural 3:40 Dy CM D K Shivakumar's Brother D K Suresh Battles It Out With C N Manjunath At Bengaluru Rural
Talking Tech & Innovation With Tata Motors’ Sven Patuschka 22:52 Talking Tech & Innovation With Tata Motors’ Sven Patuschka
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

No Data For Block Deal.

*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Oct 18, 2023 Sell
Aarti Drugs Ltd. ,GRAVITON RESEARCH CAPITAL LLP
  • Qty 480077
  • Average Price ₹554.70
Oct 18, 2023 PURCHASE
Aarti Drugs Ltd. ,GRAVITON RESEARCH CAPITAL LLP
  • Qty 480077
  • Average Price ₹554.17
Jul 25, 2023 PURCHASE
Aarti Drugs Ltd. ,GRAVITON RESEARCH CAPITAL LLP
  • Qty 933060
  • Average Price ₹627.89
Jul 25, 2023 Sell
Aarti Drugs Ltd. ,GRAVITON RESEARCH CAPITAL LLP
  • Qty 933060
  • Average Price ₹628.40
Jul 24, 2023 Sell
Aarti Drugs Ltd. ,QE SECURITIES
  • Qty 505851
  • Average Price ₹587.73
Jul 24, 2023 Sell
Aarti Drugs Ltd. ,NK SECURITIES RESEARCH PRIVATE LIMITED
  • Qty 553535
  • Average Price ₹588.59
Jul 24, 2023 PURCHASE
Aarti Drugs Ltd. ,NK SECURITIES RESEARCH PRIVATE LIMITED
  • Qty 553535
  • Average Price ₹588.25
Jul 24, 2023 Sell
Aarti Drugs Ltd. ,GRAVITON RESEARCH CAPITAL LLP
  • Qty 643754
  • Average Price ₹576.46
Jul 24, 2023 PURCHASE
Aarti Drugs Ltd. ,GRAVITON RESEARCH CAPITAL LLP
  • Qty 643754
  • Average Price ₹575.88
Jul 24, 2023 PURCHASE
Aarti Drugs Ltd. ,QE SECURITIES
  • Qty 497273
  • Average Price ₹587.77
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Aarti Drugs Ltd share price previously?
Aarti Drugs Ltd share price was up by 3.37% from the previous closing price of ₹434.30.
Who are peers of Aarti Drugs Ltd?
The peers of Aarti Drugs Ltd are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Zydus Lifesciences Ltd, Mankind Pharma Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Lupin Ltd, Aurobindo Pharma Ltd, Alkem Laboratories Ltd, Glaxosmithkline Pharmaceuticals Ltd, Biocon Ltd, Ipca Laboratories Ltd, Gland Pharma Ltd, Syngene International Ltd,
Who is/are the promoter/promoters of Aarti Drugs Ltd?
The promotor/promotors of Aarti Drugs Ltd are Prakash M Patil, Rashesh C Gogri, Harshit M Savla, Harit P Shah, Uday M Patil, Narendra Jagannath Salvi, Navin Chapshi Shah, Krishnacharya G Akamanchi, Priti Savla, Ankit Vikram Paleja, Bhaskar Narayan Thorat, Neha Gada.
What has been 52-week high of Aarti Drugs Ltd stocks?
The highest price of Aarti Drugs Ltd stock is ₹645.75 in the last 52-week.
What is the share price of Aarti Drugs Ltd (AARTIDRUGS) today on NSE?
As on Apr 01, 2024, Aarti Drugs Ltd (AARTIDRUGS)’s share price on NSE is Rs 452.3
What is the market cap of Aarti Drugs Ltd (AARTIDRUGS?)
The current market capitalisation of Aarti Drugs Ltd (AARTIDRUGS) is 3,992.74 crores
What is Aarti Drugs Ltd Share symbol?
The symbol of Aarti Drugs Ltd is AARTIDRUGS.
What is the PE ratio of Aarti Drugs Ltd (AARTIDRUGS)?
The current PE ratio of Aarti Drugs Ltd (AARTIDRUGS) is 22.14.
What is the PB ratio of Aarti Drugs Ltd (AARTIDRUGS)?
The current PB ratio of Aarti Drugs Ltd (AARTIDRUGS) is 3.30.
Today’s High & Low share prices of Aarti Drugs Ltd (AARTIDRUGS) on NSE?
Today, the share price of Aarti Drugs Ltd (AARTIDRUGS) on NSE touched a high of Rs 452.95 and a low of Rs 436.5
What price did Aarti Drugs Ltd (AARTIDRUGS) shares open on the NSE today?
On NSE, the share price of Aarti Drugs Ltd (AARTIDRUGS) opened at Rs 436.5
What is the 52-week high of Aarti Drugs Ltd (AARTIDRUGS)?
The 52-week high price of Aarti Drugs Ltd (AARTIDRUGS) is Rs 645.75
What is the 52-week low of Aarti Drugs Ltd (AARTIDRUGS) ?
The 52-week low price of Aarti Drugs Ltd (AARTIDRUGS) is Rs 332.05

ABOUT AARTI DRUGS

Aarti Drugs Ltd, incorporated in the year 1984, has its registered office in Plot No N-198 MIDC Tarapur, Pamtembhi Village Palghar Tal, Thane, Maharashtra, 401506, 91-22-24072249, 91-22-24073462/24070144. The main industry in which Aarti Drugs Ltd operates is Pharmaceuticals - Indian - Bulk Drugs.

Auditor/Auditors for Aarti Drugs Ltd is/are Kirtane & Pandit LLP. In the main management, Prakash M Patil is chairman and is the company secretary for Aarti Drugs Ltd.

  • PMP Prakash M Patil CMD & Executive Director
  • RCG Rashesh C Gogri ED / MD / Promoter
  • HMS Harshit M Savla ED / Joint MD / Promoter
  • HPS Harit P Shah E D & Wholetime Director
  • UMP Uday M Patil WTD & Executive Director
  • NJS Narendra Jagannath Salvi Non Executive Director
  • NCS Navin Chapshi Shah Independent Non Exe. Director
  • KGA Krishnacharya G Akamanchi Independent Non Exe. Director
  • PS Priti Savla Independent Non Exe. Director
  • AVP Ankit Vikram Paleja Independent Non Exe. Director
  • BNT Bhaskar Narayan Thorat Independent Non Exe. Director
  • NG Neha Gada Independent Non Exe. Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement